跳至主要内容
临床试验/NL-OMON29231
NL-OMON29231已完成不适用

Assessment of the value of a sFlt-1/PlGF ratio test in the classification and treatment of patients with (suspected) preeclampsia in the Dutch obstetrical care system

MC0 个研究点目标入组 400 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
MC
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Subjects enrolled in the study must meet the following inclusion criteria:
  • 1) Age = 16 years
  • 2) Gestational age of from 20 weeks and 0 days
  • 3) Signed written informed consent
  • 4) a. Suspected preeclampsia as a protocol defined definition stated in Appendix Table 2
  • b. Confirmed preeclampsia as defined by the International Society for the Study of Hypertension in Pregnancy (ISSHP)

排除标准

  • Subjects will be excluded from participation if they meet any of the following exclusion criteria:
  • 1) Insufficient understanding of Dutch language

研究者

发起方
MC

相似试验

已完成
不适用
Assessing the use of pregnancy biomarkers (blood test), to identify women at risk of placental insufficiency in order to optimise their antenatal care.pre eclampsiaplacental insufficiencyReproductive Health and Childbirth - Fetal medicine and complications of pregnancyReproductive Health and Childbirth - Antenatal careintrauterine growth restriction
ACTRN12620001186943niversity of Otago240
尚未招募
Unknown
se of the Placental Growth Factor (PlGF) test in pregnant women with Chronic Hypertension to evaluate superimposed Pre-eclampsiaEssential HypertensionPre-eclampsia
RBR-2zx5y9rHospital da Mulher Professor Doutor José Aristodemo Pinotti - Centro de Atenção Integral à Saúde da Mulher
招募中
不适用
Homoeopathic Treatment for Osteoarthritis
CTRI/2022/06/042995ational Institute of Homoeopathy
已完成
不适用
Diagnostic Value of sFlt-1/PlGF Ratio for the Etiology of Intra Uterine Growth Restriction - ANGIOPAGFetal Growth Restriction (FGR)Intrauterine Growth Restriction
NCT05151289Assistance Publique - Hôpitaux de Paris167
招募中
不适用
Assessing the use of pregnancy biomarkers (blood test) in women with pre-existing diabetes, to identify women at risk of placental insufficiency in order to optimise their antenatal carepre-eclampsiaplacental insufficiencyfetal growth restrictionType 2 diabetesReproductive Health and Childbirth - Antenatal careReproductive Health and Childbirth - Fetal medicine and complications of pregnancyMetabolic and Endocrine - DiabetesType 1 diabetes
ACTRN12622001159741Ruth Hughes90